CDER’s Manual of Policies and Procedures (MAPPs) are federal directives and documentation of internal policies and procedures.
Similar Posts
How to Participate in Emerging Technology Program (ETP)
CDER’s Office of Pharmaceutical Quality created the Emerging Technology Program to promote the adoption of innovative approaches to pharmaceutical product design and manufacturing.Alert: Siemens Healthineers Issues Correction for 3 Tesla MRI Systems
Siemens Healthineers is correcting 3 Tesla MRI systems including MAGNETOM and BioGraph mMR due to the potential for ice blockage in the magnet venting systemChemistry, Manufacturing, and Controls Development and Readiness Pilot (CDRP) Program
Chemistry, Manufacturing, and Controls Development and Readiness Pilot Program (CDRP)Recall Alert: Max Mobility/Permobil Removes All SpeedControl Dials Used with SmartDrive MX2+ Power Assist Devices
SpeedControl Dials used with SmartDrive MX2+ Power Assist Devices may be unresponsive to users and fail to stop or start unexpectedly, causing injuryICH M13B Webinar: Navigating the Draft ICH M13B Additional Strengths Biowaiver Guideline – 09/11/2025
This webinar will provide an in-depth look at the draft ICH M13B guideline titled “Bioequivalence for Immediate-Release Solid Oral Dosage Forms: Additional Strengths Biowaiver” that was endorsed by the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) Assembly in March 2025.eCTD Submission Standards for eCTD v3.2.2 and Regional M1
eCTD Submission Standards